SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ALTAREX CORP. (TSE: AXO)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (247)10/25/2000 9:12:24 AM
From: Mark J. Redmond  Read Replies (1) of 274
 
I agree that all biotech's face a long road to success. As I read between the lines I see that the AXO technology is being proven out as a broad platform from which multiple cancer targets can be attacked, and the AXO are getting a handle on this unique technology. There is real depth to this company's technology!

The outstanding issue is that a partner or partners are needed to take these products through to market. To date this company is supported mainly from Canadian investors and we have not seen management's ability to raise US institutional or industrial backing. We know that these activities are on-going and as time passes the need for cash will become more critical.

On the upside, US based support will be by partners who want to see this stock soar!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext